These findings suggest that NY-ESO-1 and MAGE-A4 could serve as predictive markers in soft tissue sarcomas and other malignancies with a high metastatic propensity, such as locally advanced rectal cancer [42]. This evidence concerns the gene MAGEA4 and rectal cancer.